NCT07731243 Vibration, Massage, and Myofascial Release in Primary Dysmenorrhea
| NCT ID | NCT07731243 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Istanbul Medipol University Hospital |
| Condition | Dysmenorrhea Primary |
| Study Type | INTERVENTIONAL |
| Enrollment | 96 participants |
| Start Date | 2026-07-14 |
| Primary Completion | 2026-11-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 96 participants in total. It began in 2026-07-14 with a primary completion date of 2026-11-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This randomized, assessor-blinded, four-arm, parallel-group controlled trial aims to compare the effects of vibration therapy, abdominal massage, and myofascial release with an education-only control intervention in women with primary dysmenorrhea. Seventy-two women aged 18 to 30 years will be randomized in a 1:1:1:1 ratio. All participants will receive standard education about primary dysmenorrhea. The three intervention groups will additionally receive their assigned treatment twice weekly for 12 weeks, covering three menstrual cycles. Menstrual pain, pain characteristics, pressure pain threshold, menstrual symptoms, and symptoms associated with central sensitization will be evaluated at baseline and after the intervention by a blinded assessor.
Eligibility Criteria
* Inclusion Criteria: * Female participants aged 18 to 30 years. * Having regular menstrual cycles during the previous 6 months. * Having a diagnosis consistent with primary dysmenorrhea following evaluation by an obstetrician and gynecologist. * Experiencing menstrual pain in at least 2 of the previous 3 menstrual cycles. * Having menstrual pain intensity of 4 or higher on a 0-10 Visual Analog Scale. * Voluntarily agreeing to participate in the study and providing written informed consent. Exclusion Criteria: * Secondary dysmenorrhea. * Diagnosis of endometriosis, uterine fibroids, ovarian cysts, or pelvic inflammatory disease. * History of gynecological surgery. * Pregnancy or suspected pregnancy. * Having given birth within the previous 6 months. * Recent initiation of hormonal treatment. * Chronic pelvic pain or a neurological, rheumatological, or systemic inflammatory disease. * Having received manual therapy or physiotherapy targeting the abdominal or lumbopelvic region within the previous 3 months. * Skin lesions, infection, open wounds, or other dermatological conditions in the treatment regions. * Any clinical condition considered a contraindication to vibration therapy. * Inability to comply with the study protocol -
Frequently Asked Questions
Who can join the NCT07731243 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 30 Years, studying Dysmenorrhea Primary. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07731243 currently recruiting?
Yes, NCT07731243 is actively recruiting participants. Visit ClinicalTrials.gov or contact Istanbul Medipol University Hospital to inquire about joining.
Where is the NCT07731243 trial being conducted?
This trial is being conducted at Istanbul, Turkey (Türkiye).
Who is sponsoring the NCT07731243 clinical trial?
NCT07731243 is sponsored by Istanbul Medipol University Hospital. The trial plans to enroll 96 participants.